Pinuccia Valagussa Selected Research

Pinuccia Valagussa Research Topics

Disease

28	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2003
16	Neoplasms (Cancer) 01/2022 - 01/2002
4	Inflammatory Breast Neoplasms 06/2016 - 01/2010
4	Hodgkin Disease (Hodgkin's Disease) 07/2011 - 07/2004
3	Pathologic Complete Response 01/2017 - 10/2005
2	Neutropenia 01/2018 - 06/2016
2	Multiple Myeloma 03/2013 - 09/2003
2	Neoplasm Metastasis (Metastasis) 03/2010 - 04/2004
1	Stomatitis 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017
1	Febrile Neutropenia 06/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2016
1	Triple Negative Breast Neoplasms 07/2014
1	Thrombosis (Thrombus) 05/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2014
1	Sarcoma (Soft Tissue Sarcoma) 03/2012
1	Heart Failure 01/2010
1	Breast Cancer 3 01/2010
1	Familial ependymoma 04/2004
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2003
1	Disease Progression 01/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2002
1	Esophageal Squamous Cell Carcinoma 01/2002

Drug/Important Bio-Agent (IBA)

11	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 02/2003
8	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2010
8	Fluorouracil (Carac)FDA LinkGeneric 04/2012 - 05/2004
8	Methotrexate (Mexate)FDA LinkGeneric 04/2012 - 05/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2011 - 05/2004
6	Paclitaxel (Taxol)FDA LinkGeneric 03/2018 - 10/2005
5	pertuzumabIBA 01/2022 - 01/2012
5	AnthracyclinesIBA 01/2019 - 10/2005
3	Hormones (Hormone)IBA 01/2022 - 01/2012
3	Docetaxel (Taxotere)FDA Link 01/2017 - 01/2012
3	Estrogen ReceptorsIBA 04/2012 - 12/2005
3	Vinblastine (Vinblastine Sulfate)FDA Link 07/2011 - 07/2004
3	Bleomycin (Blenoxane)FDA LinkGeneric 07/2011 - 07/2004
3	Dacarbazine (DIC)FDA LinkGeneric 07/2011 - 07/2004
2	palbociclibIBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	taxaneIBA 01/2019 - 04/2012
2	human ERBB2 proteinIBA 03/2018 - 02/2003
2	Pharmaceutical PreparationsIBA 05/2014 - 01/2012
2	Capecitabine (Xeloda)FDA Link 04/2012 - 10/2006
2	Prednisone (Sone)FDA LinkGeneric 07/2011 - 05/2005
2	Vincristine (Oncovin)FDA LinkGeneric 07/2011 - 05/2005
2	Procarbazine (Matulane)FDA Link 07/2011 - 05/2005
2	Monoclonal AntibodiesIBA 01/2010 - 02/2003
1	Estrogens (Estrogen)FDA Link 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 03/2018
1	Albumin-Bound Paclitaxel FDA Link 03/2018
1	Phenobarbital (Luminal)FDA Link 03/2018
1	Aromatase InhibitorsIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	antineoplaston A10 (A 10)IBA 06/2016
1	Indicators and Reagents (Reagents)IBA 06/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2016
1	Brentuximab VedotinIBA 01/2016
1	Bortezomib (Velcade)FDA Link 03/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2013
1	exemestane (Aromasin)FDA Link 04/2012
1	Etoposide (VP 16)FDA LinkGeneric 07/2011
1	Hyaluronic Acid (Hyaluronan)IBA 01/2008
1	CarbamatesIBA 10/2006
1	ProdrugsIBA 10/2006
1	ParaffinIBA 10/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2005
1	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2005
1	Biological ProductsIBA 07/2003
1	Therapeutic UsesIBA 02/2003
1	Dihydrotachysterol (AT 10)IBA 01/2002

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
10	Neoadjuvant Therapy 01/2022 - 07/2003
8	Therapeutics 01/2022 - 02/2003
5	Radiotherapy 07/2011 - 01/2002
3	Stem Cell Transplantation 01/2020 - 09/2003
3	Adjuvant Chemotherapy 03/2012 - 02/2003
3	Mastectomy (Mammectomy) 03/2010 - 01/2004
2	Salvage Therapy 01/2022 - 07/2010